Without this delivery method, you may be wasting your investment on a supplement that your body cannot fully use
Through refinement of mechanism, personalization of intervention strategies, and scaling of clinical evidence, microbiome research is expected to advance from laboratory to clinical practice, ultimately providing DGE patients with novel therapeutic regimens that integrate neural repair, metabolic regulation, safety, and tolerability, thereby tangibly improving their gastrointestinal function and quality of life
Retatrutide doesnt have a UK licence, so no UK clinician, GP or otherwise, can lawfully prescribe it
Retatrutide is a 39-amino-acid triple agonist peptide (GLP-1, GIP, and glucagon receptors) that produced 28.7% body weight loss in Phase 3 trials (Lilly Press Release, Dec 2025)
This delivery system is often much gentler on the digestive tract and is a great alternative for those who experience discomfort with standard forms